MedPath

Northwestern University Human Resources

Northwestern University Human Resources logo
🇺🇸United States
Ownership
Private
Established
1851-01-28
Employees
5K
Market Cap
-
Website
https://www.venturecat.northwestern.edu

Characterization of Lipoprotein Composition and Function in Pediatric Psoriasis Before and After Treatment

Active, not recruiting
Conditions
Psoriasis
Interventions
Other: Fasting blood draw for lipid assessments
First Posted Date
2019-01-02
Last Posted Date
2025-04-27
Lead Sponsor
Northwestern University
Target Recruit Count
62
Registration Number
NCT03791216
Locations
🇺🇸

Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States

Maximizing Outcomes for Preschoolers With Developmental Language Disorders

Phase 2
Completed
Conditions
Developmental Language Disorder
Interventions
Behavioral: the Enhanced Milieu Teaching-Sentence Focus
First Posted Date
2018-12-20
Last Posted Date
2025-04-01
Lead Sponsor
Northwestern University
Target Recruit Count
108
Registration Number
NCT03782493
Locations
🇺🇸

Northwestern University, Evanston, Illinois, United States

🇺🇸

Vanderbilt University, Nashville, Tennessee, United States

Wearable Skin Sensors to Assess Nocturnal Scratch Behavior

Completed
Conditions
Atopic Dermatitis
Interventions
Device: Scratch sensor
First Posted Date
2018-12-10
Last Posted Date
2023-10-13
Lead Sponsor
Northwestern University
Target Recruit Count
23
Registration Number
NCT03770858
Locations
🇺🇸

Northwestern University, Chicago, Illinois, United States

Genetic Analysis of Pediatric Psoriasis

Completed
Conditions
Psoriasis
Interventions
Other: Saliva or buccal sample
First Posted Date
2018-12-07
Last Posted Date
2022-04-20
Lead Sponsor
Northwestern University
Target Recruit Count
86
Registration Number
NCT03768284
Locations
🇺🇸

Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States

Redesigning Systems to Improve Quality for Hospitalized Patients

Not Applicable
Completed
Conditions
Adverse Event
Interdisciplinary Communication
Interpersonal Relations
Interprofessional Relations
Interventions
Behavioral: Advanced and Integrated MicroSystems (AIMS) interventions
First Posted Date
2018-11-19
Last Posted Date
2023-01-12
Lead Sponsor
Northwestern University
Target Recruit Count
4265
Registration Number
NCT03745677
Locations
🇺🇸

Alamance Regional Medical Center, Burlington, North Carolina, United States

🇺🇸

Baptist Hospital, Pensacola, Florida, United States

🇺🇸

Legacy Good Samaritan Hospital, Portland, Oregon, United States

and more 1 locations

Nicotinamide Riboside With and Without Resveratrol to Improve Functioning in Peripheral Artery Disease

Phase 3
Completed
Conditions
Peripheral Artery Disease
Interventions
First Posted Date
2018-11-16
Last Posted Date
2025-01-14
Lead Sponsor
Northwestern University
Target Recruit Count
90
Registration Number
NCT03743636
Locations
🇺🇸

Northwestern University, Chicago, Illinois, United States

Combination Chemotherapy and TAK-659 as Front-Line Treatment in Treating Patients With High-Risk Diffuse Large B Cell Lymphoma

Phase 1
Active, not recruiting
Conditions
Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type
Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
T-Cell/Histiocyte-Rich Large B-Cell Lymphoma
Diffuse Large B-Cell Lymphoma Activated B-Cell Type
High Grade B-Cell Lymphoma, Not Otherwise Specified
Diffuse Large B-Cell Lymphoma
High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements
Interventions
First Posted Date
2018-11-15
Last Posted Date
2025-02-11
Lead Sponsor
Northwestern University
Target Recruit Count
12
Registration Number
NCT03742258
Locations
🇺🇸

Northwestern Lake Forest Hospital, Lake Forest, Illinois, United States

🇺🇸

Northwestern University, Chicago, Illinois, United States

Pembrolizumab and Pelareorep in Treating Patients With Advanced Pancreatic Cancer

Phase 2
Terminated
Conditions
Pancreatic Adenocarcinoma
Stage III Pancreatic Cancer AJCC v8
Stage IV Pancreatic Cancer AJCC v8
Interventions
Biological: Pembrolizumab
Biological: Wild-type Reovirus
First Posted Date
2018-10-30
Last Posted Date
2022-10-05
Lead Sponsor
Northwestern University
Target Recruit Count
17
Registration Number
NCT03723915
Locations
🇺🇸

Northwestern University, Chicago, Illinois, United States

High Intensity Walking to Reduce Frailty

Not Applicable
Terminated
Conditions
Frailty
Interventions
Behavioral: High Intensity Walking
Behavioral: Casual Speed Walking
First Posted Date
2018-10-17
Last Posted Date
2021-03-04
Lead Sponsor
Northwestern University
Target Recruit Count
59
Registration Number
NCT03709251
Locations
🇺🇸

Northwestern Univiersity Department of Physical Therapy and Human Movement Sciences, Chicago, Illinois, United States

Nivolumab and Combination Chemotherapy in Treating Participants With Diffuse Large B-Cell Lymphoma

Phase 1
Suspended
Conditions
Diffuse Large B-Cell Lymphoma Unclassifiable
Intravascular Large B-Cell Lymphoma
Primary Mediastinal (Thymic) Large B-Cell Lymphoma
T-Cell/Histiocyte-Rich Large B-Cell Lymphoma
Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma
CD20 Positive
B-Cell Non-Hodgkin Lymphoma
Aggressive Non-Hodgkin Lymphoma
Interventions
Biological: Nivolumab
Other: Quality-of-Life Assessment
Biological: Rituximab
First Posted Date
2018-10-15
Last Posted Date
2022-08-15
Lead Sponsor
Northwestern University
Target Recruit Count
30
Registration Number
NCT03704714
Locations
🇺🇸

Northwestern University- Lake Forest Hospital, Lake Forest, Illinois, United States

🇺🇸

Northwestern Medicine: Delnor, DuPage, Warrenville, Kishwaukee (West Region), Warrenville, Illinois, United States

🇺🇸

Northwestern University, Chicago, Illinois, United States

and more 1 locations
© Copyright 2025. All Rights Reserved by MedPath